RELB and non-small cell lung carcinoma: In particular, cytoplasmic NF-κB2 and RelB were detected in 97.4% and 67.1% of NSCLC specimens, while nuclear immunostaining for NF-κB2 and RelB was observed in 18.7% and 47.2%, respectively.